ArticleBMC pregnancy and childbirth2025
Indoor residual spraying household visits as a platform for engaging pregnant women in malaria prevention on Bioko Island, Equatorial Guinea.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPregnant women are particularly vulnerable to many health conditions, including infectious diseases, which place them at elevated risk of severe outcomes. In particular, malaria poses a significant burden during pregnancy, and as such there has long been a strong focus on delivering malaria prevention interventions to pregnant women during antenatal care (ANC), including long-lasting insecticide-treated nets (LLINs) and intermittent preventive treatment in pregnancy (IPTp). However, outreach to drive uptake of these interventions presents some distinct challenges. For example, pregnant women may not attend ANC or may not do it in public health facilities, where these interventions are freely available, precluding access. In this study, an implementation of routine annual indoor residual spraying (IRS) on Bioko Island, Equatorial Guinea was leveraged to identify pregnant women and conduct follow-up visits focused on awareness and uptake of LLINs and IPTp.
methodsIRS campaign data was used to generate lists of households with pregnant women for follow-up visits, during which communication agents conducted an interview based on relevant sections of a malaria indicator survey to assess knowledge about malaria, LLINs and IPTp, and uptake of these interventions. Uptake was defined on an ordinal, three-category scale, and ordinal regression modeling was performed to assess the relationship between uptake and knowledge indicators.
resultsIn total, 1,567 households were visited, and 589 pregnant women identified. There was a high awareness about LLINs (76.9% cited LLINs as a malaria prevention method), but low awareness of IPTp (34.5% could cite any benefit and 37.1% were aware of availability in public health facilities). In line with awareness levels, regular use of LLINs (54.8% reported using every night) was higher than IPTp uptake (35.2% on track for three doses). Ordinal regression modelling confirmed that LLIN use on some or all nights was associated with awareness that LLINs prevent malaria, and IPTp uptake was associated with awareness of the number of doses required.
conclusionsThis work demonstrated that complementary malaria control interventions can be leveraged to identify pregnant women for further outreach. The information collected provides a baseline to evaluate the impact of future activities on Bioko Island and suggests that increasing awareness of IPTp could improve coverage, while further increasing LLIN use will likely require identifying specific barriers to use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.